Drawing for EYECARE MADE EASY

USPTO serial 97524576

EYECARE MADE EASY

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SINGH, DEEP K
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with EYECARE MADE EASY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,545*

Plus Government fees of $750

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Thomas J. Perkowski

Thomas J. Perkowski THOMAS J. PERKOWSKI, ESQ., PC6 THORNDAL CIRCLE, SUITE 206DARIEN, CT 06820United States

Goods and services

ClassDescriptionStatusFirst use
003Preparations for cleaning the eyes and eyelids, namely, eye-washes not for medical purposes; non-medicated eye wipes; makeup removal wipes, namely, tissues impregnated with make-up removing preparations; Non-medicated cleansers for personal use, namely, facial and eye wipes impregnated with a skin cleanser; eye cleaner, namely, eye cleansing hygienic wipes impregnated with cleansing solution; eye compresses for cosmetic purposes, namely, non-microwaveable warm eye compresses, hydro-gel eye masks; gel eye masks; skin moisturizer masks; Non-medicated skin care preparations, namely, eye masks impregnated with beneficial skin preparation; cool eye compresses for cosmetic purposes; Non-medicated skin care preparations, namely, non-refrigerated cooling eye maskACTIVE—
005Vitamins, dietary and nutritional supplements that promote ocular health; ophthalmic preparations and substances for the provision of optimum eye function; Multivitamin preparations, namely, multivitamin preparations for promoting ocular health; Multivitamin preparations, namely, multivitamin preparations for promoting retinal health; Multivitamin preparations, namely, multivitamin preparations for promoting general health and eye health; Pharmaceutical preparations for the treatment of eye diseases and conditions; ophthalmic solutions, formulations and preparations for dry eye therapy in the nature of lubricant eye drops, eye solutions, eye gels, antibiotic eye ointments, antibiotic eyelid ointment, artificial tears and tear serum for medical purposes; cyclosporine eye drops; ophthalmic preparations, namely, liftigrast eye drops; medicated eye drops; contact lens solution; preservative free contact lens solution; preservative free artificial tears; artificial tears; tear serums in the nature of eye dropsACTIVE—
009Downloadable computer software systems for providing computer programs and services to others for the purposes of recognition and treatment of ocular diseases in humans, including Dry Eye Disease; Downloadable computer software systems for providing computer programs and services to others involving providing virtual consultation services to patients relating to the diagnosis and treatment of ocular conditions; Downloadable computer software systems for providing computer programs and services to others involving providing educational services via an online portal and community portal to promote education and best practices for maintaining ocular health, disease treatment and prevention; Downloadable computer software systems for providing computer programs and services to others involving online services enabling the ordering, fulfillment and delivery of ocular health, disease treatment and prevention products, namely, ophthalmic prescriptions, preparations for cleaning the eyes and eyelids, eye wipes, eyelid wipes, makeup removal wipes, facial wipes, eye cleaner, eye compresses including non-microwaveable warm eye compresses, heat adjustable eye compresses, cool eye compresses, pharmaceutical preparations for the eye, ophthalmic solutions, formulations and preparations for dry eye therapy in the nature of non-medicated eye washes, vitamins, dietary and nutritional supplements that promote ocular health, ophthalmic preparations and substances for the provision of optimum eye function; Downloadable computer software systems for providing computer programs and services to others for the purposes of providing online services supporting clinical trials and market studies involving ocular health, disease treatment and prevention; Downloadable computer software systems for providing computer programs and services to others for the purposes of providing online services supporting professional ophthalmic services, namely, ocular health, disease treatment and prevention; Recorded audiovisual animations concerning eye health, disease prevention and treatment; video recordings featuring ocular health, disease treatment and prevention content; downloadable movies concerning eye health, disease prevention and treatment; Downloadable electronic publications with evergreen content, namely, online articles, e-books, brochures, and blogs in the nature of online journals concerning ocular health, disease treatment and preventionACTIVE—
016Printed paper books, printed magazines and printed publications, namely, brochures, booklets, and workbooks concerning eye health, disease prevention and treatment; printed educational materials and educational publications, namely, books, hand-outs, and workbooks, and educational booklets concerning ocular health, disease treatment and preventionACTIVE—
042Platform as a service (PaaS) featuring computer software platforms and systems for providing programs and services to others for the purposes of recognition and treatment of ocular diseases in humans, including Dry Eye Disease; Platform as a service (PaaS) featuring computer software platforms and systems for providing programs and services to others, involving providing virtual consultation services to others relating to ocular health, disease treatment and prevention; Platform as a service (PaaS) featuring computer software platforms and systems for providing programs and services to others, involving educational services via an online portal and community portal to promote education and best practices for maintaining ocular health, disease treatment and prevention; Platform as a service (PaaS) featuring computer software platforms and systems for providing programs and services to others, involving the ordering and delivery of products promoting ocular health, disease treatment and prevention, namely, ophthalmic prescriptions, non-medicated eye lotions, preparations for cleaning the eyesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 13, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 12, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 11, 2026EXT5SOU EXTENSION 5 FILED—
Aug 11, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 17, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 13, 2026EX4GSOU EXTENSION 4 GRANTED—
Feb 13, 2026EXT4SOU EXTENSION 4 FILED—
Feb 13, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 13, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 13, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 12, 2026EX3GSOU EXTENSION 3 GRANTED—
Nov 17, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 9, 2025TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Oct 9, 2025NREVNOTICE OF REVIVAL - E-MAILED—
Oct 9, 2025PETGPETITION TO REVIVE-GRANTED—
Oct 9, 2025PROATEAS PETITION TO REVIVE RECEIVED—
Oct 9, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 9, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 13, 2025EXT3SOU EXTENSION 3 FILED—
Aug 13, 2025EX2GSOU EXTENSION 2 GRANTED—
Feb 13, 2025EXT2SOU EXTENSION 2 FILED—
Jul 5, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 5, 2024EX1GSOU EXTENSION 1 GRANTED—
Jul 5, 2024EXT1SOU EXTENSION 1 FILED—
Jul 5, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 13, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 19, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 19, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 13, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Nov 13, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 13, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 13, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 19, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 19, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 19, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 16, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 16, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 8, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jul 3, 2023DOCKASSIGNED TO EXAMINER—
May 10, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2023DOCKASSIGNED TO EXAMINER—
Aug 19, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 1, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance